Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella, S Stowasser, L Wollin - Drug design, development and …, 2015 - Taylor & Francis
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
[PDF][PDF] Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella - Drug Design, Development and Therapy, 2015 - researchgate.net
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella, S Stowasser… - Drug design …, 2015 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib.
F Bonella, S Stowasser, L Wollin - Drug Design, Development and …, 2015 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
[PDF][PDF] Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella - Drug Design, Development and Therapy, 2015 - Citeseer
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
[PDF][PDF] Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella - Drug Design, Development and Therapy, 2015 - pdfs.semanticscholar.org
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella, S Stowasser, L Wollin - Drug Design, Development and …, 2015 - dovepress.com
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
[HTML][HTML] Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella, S Stowasser, L Wollin - Drug Design, Development and …, 2015 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella, S Stowasser, L Wollin - Drug Design, Development and …, 2015 - go.gale.com
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
[PDF][PDF] Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
F Bonella - Drug Design, Development and Therapy, 2015 - scienceopen.com
Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …
pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of …